vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and FIRST ADVANTAGE CORP (FA). Click either name above to swap in a different company.

FIRST ADVANTAGE CORP is the larger business by last-quarter revenue ($420.0M vs $268.1M, roughly 1.6× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 1.4% vs 0.8%, a 0.5% gap on every dollar of revenue. On growth, FIRST ADVANTAGE CORP posted the faster year-over-year revenue change (36.8% vs 9.7%). Over the past eight quarters, FIRST ADVANTAGE CORP's revenue compounded faster (57.5% CAGR vs 5.3%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

First Advantage Corp is a leading global provider of end-to-end workforce screening and background verification solutions. It serves clients across diverse sectors including technology, healthcare, finance, retail, and manufacturing, ranging from small businesses to large multinational enterprises, helping reduce hiring risks, meet regulatory requirements, and build secure, trusted work environments globally.

ACAD vs FA — Head-to-Head

Bigger by revenue
FA
FA
1.6× larger
FA
$420.0M
$268.1M
ACAD
Growing faster (revenue YoY)
FA
FA
+27.0% gap
FA
36.8%
9.7%
ACAD
Higher net margin
ACAD
ACAD
0.5% more per $
ACAD
1.4%
0.8%
FA
Faster 2-yr revenue CAGR
FA
FA
Annualised
FA
57.5%
5.3%
ACAD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ACAD
ACAD
FA
FA
Revenue
$268.1M
$420.0M
Net Profit
$3.6M
$3.5M
Gross Margin
Operating Margin
-1.7%
10.7%
Net Margin
1.4%
0.8%
Revenue YoY
9.7%
36.8%
Net Profit YoY
103.5%
EPS (diluted)
$0.02
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
FA
FA
Q1 26
$268.1M
Q4 25
$284.0M
$420.0M
Q3 25
$278.6M
$409.2M
Q2 25
$264.6M
$390.6M
Q1 25
$244.3M
$354.6M
Q4 24
$259.6M
$307.1M
Q3 24
$250.4M
$199.1M
Q2 24
$242.0M
$184.5M
Net Profit
ACAD
ACAD
FA
FA
Q1 26
$3.6M
Q4 25
$273.6M
$3.5M
Q3 25
$71.8M
$2.6M
Q2 25
$26.7M
$308.0K
Q1 25
$19.0M
$-41.2M
Q4 24
$143.7M
$-100.4M
Q3 24
$32.8M
$-8.9M
Q2 24
$33.4M
$1.9M
Gross Margin
ACAD
ACAD
FA
FA
Q1 26
Q4 25
90.8%
Q3 25
92.2%
Q2 25
92.2%
Q1 25
91.7%
Q4 24
91.6%
Q3 24
92.5%
Q2 24
92.5%
Operating Margin
ACAD
ACAD
FA
FA
Q1 26
-1.7%
Q4 25
6.1%
10.7%
Q3 25
12.8%
10.3%
Q2 25
12.2%
9.7%
Q1 25
7.9%
2.1%
Q4 24
59.1%
-26.3%
Q3 24
12.6%
4.6%
Q2 24
12.6%
5.4%
Net Margin
ACAD
ACAD
FA
FA
Q1 26
1.4%
Q4 25
96.3%
0.8%
Q3 25
25.8%
0.6%
Q2 25
10.1%
0.1%
Q1 25
7.8%
-11.6%
Q4 24
55.4%
-32.7%
Q3 24
13.1%
-4.4%
Q2 24
13.8%
1.0%
EPS (diluted)
ACAD
ACAD
FA
FA
Q1 26
$0.02
Q4 25
$1.61
$0.03
Q3 25
$0.42
$0.01
Q2 25
$0.16
$0.00
Q1 25
$0.11
$-0.24
Q4 24
$0.86
$-0.67
Q3 24
$0.20
$-0.06
Q2 24
$0.20
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
FA
FA
Cash + ST InvestmentsLiquidity on hand
$240.0M
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$1.3B
Total Assets
$1.6B
$3.8B
Debt / EquityLower = less leverage
1.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
FA
FA
Q1 26
Q4 25
$177.7M
$240.0M
Q3 25
$258.0M
$216.8M
Q2 25
$253.6M
$184.3M
Q1 25
$217.7M
$172.0M
Q4 24
$319.6M
$168.7M
Q3 24
$155.1M
$307.4M
Q2 24
$177.1M
$269.6M
Total Debt
ACAD
ACAD
FA
FA
Q1 26
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.1B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
Q2 24
Stockholders' Equity
ACAD
ACAD
FA
FA
Q1 26
Q4 25
$1.2B
$1.3B
Q3 25
$917.3M
$1.3B
Q2 25
$822.4M
$1.3B
Q1 25
$765.2M
$1.3B
Q4 24
$732.8M
$1.3B
Q3 24
$577.2M
$920.7M
Q2 24
$516.7M
$913.3M
Total Assets
ACAD
ACAD
FA
FA
Q1 26
$1.6B
Q4 25
$1.6B
$3.8B
Q3 25
$1.3B
$3.9B
Q2 25
$1.2B
$3.9B
Q1 25
$1.1B
$3.9B
Q4 24
$1.2B
$3.9B
Q3 24
$976.9M
$1.7B
Q2 24
$914.1M
$1.6B
Debt / Equity
ACAD
ACAD
FA
FA
Q1 26
Q4 25
1.61×
Q3 25
1.64×
Q2 25
1.65×
Q1 25
1.69×
Q4 24
1.66×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
FA
FA
Operating Cash FlowLast quarter
$65.9M
Free Cash FlowOCF − Capex
$62.2M
FCF MarginFCF / Revenue
14.8%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
19.01×
TTM Free Cash FlowTrailing 4 quarters
$188.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
FA
FA
Q1 26
Q4 25
$-48.7M
$65.9M
Q3 25
$74.3M
$72.4M
Q2 25
$64.0M
$37.3M
Q1 25
$20.3M
$19.5M
Q4 24
$40.4M
$-85.7M
Q3 24
$63.2M
$43.5M
Q2 24
$25.0M
$32.0M
Free Cash Flow
ACAD
ACAD
FA
FA
Q1 26
Q4 25
$62.2M
Q3 25
$73.9M
$71.2M
Q2 25
$36.1M
Q1 25
$19.0M
Q4 24
$-86.0M
Q3 24
$63.2M
$43.1M
Q2 24
$31.4M
FCF Margin
ACAD
ACAD
FA
FA
Q1 26
Q4 25
14.8%
Q3 25
26.5%
17.4%
Q2 25
9.2%
Q1 25
5.4%
Q4 24
-28.0%
Q3 24
25.2%
21.6%
Q2 24
17.0%
Capex Intensity
ACAD
ACAD
FA
FA
Q1 26
Q4 25
0.9%
Q3 25
0.1%
0.3%
Q2 25
0.3%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.0%
0.2%
Q2 24
0.4%
Cash Conversion
ACAD
ACAD
FA
FA
Q1 26
Q4 25
-0.18×
19.01×
Q3 25
1.03×
27.91×
Q2 25
2.40×
121.25×
Q1 25
1.07×
Q4 24
0.28×
Q3 24
1.93×
Q2 24
0.75×
17.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Segment breakdown not available.

FA
FA

First Advantage Americas$209.9M50%
Sterling$185.9M44%
First Advantage International$24.2M6%

Related Comparisons